98. 好酸球性消化管疾患 Eosinophilic gastrointestinal disease Clinical trials / Disease details
臨床試験数 : 172 / 薬物数 : 149 - (DrugBank : 39) / 標的遺伝子数 : 38 - 標的パスウェイ数 : 135
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05608681 (ClinicalTrials.gov) | January 2023 | 19/10/2022 | A Trial Evaluating EP-104IAR in Adults With Eosinophilic Esophagitis | A Phase 1b, Open Label Trial Evaluating the Safety, Pharmacokinetics, and Efficacy of EP-104IAR in Adults With Eosinophilic Esophagitis (EoE) | Eosinophilic Esophagitis | Drug: EP-104IAR | Eupraxia Pharmaceuticals Inc. | NULL | Not yet recruiting | 18 Years | 75 Years | All | 24 | Phase 1 | NULL |